Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (271-280 of 353) with videos related to

Pageof 36
Sort By:
The American Journal of Cardiology|February 22, 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)Abdallah G Rebeiz, Per Johanson, Cindy L Green, et al.
American Heart Journal|December 5, 2009
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working groupSunil V Rao, John Eikelboom, Ph Gabriel Steg, et al.
Journal of the American College of Cardiology|April 1, 2011
2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Obesity (Silver Spring, Md.)|December 11, 2022
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsIldiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamerThomas J Povsic, Monica G Lawrence, A Michael Lincoff, et al.
The American Journal of Cardiology|March 14, 2003
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibitionLeslie Cho, Derek P Chew, David J Moliterno, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2004
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularizationStephen G Ellis, Christopher T Bajzer, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Diabetes Care|June 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECTIldiko Lingvay, John Deanfield, Steven E Kahn, et al.
Journal of the American College of Cardiology|May 7, 2011
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic SurgeonsR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Pageof 36

Showing results (271-280 of 353) with videos related to

Sort By:
Pageof 36
The American Journal of Cardiology|February 22, 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)Abdallah G Rebeiz, Per Johanson, Cindy L Green, et al.
American Heart Journal|December 5, 2009
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working groupSunil V Rao, John Eikelboom, Ph Gabriel Steg, et al.
Journal of the American College of Cardiology|April 1, 2011
2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Obesity (Silver Spring, Md.)|December 11, 2022
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsIldiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamerThomas J Povsic, Monica G Lawrence, A Michael Lincoff, et al.
The American Journal of Cardiology|March 14, 2003
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibitionLeslie Cho, Derek P Chew, David J Moliterno, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2004
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularizationStephen G Ellis, Christopher T Bajzer, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Diabetes Care|June 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECTIldiko Lingvay, John Deanfield, Steven E Kahn, et al.
Journal of the American College of Cardiology|May 7, 2011
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic SurgeonsR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Pageof 36